Brief: Astria Therapeutics Initiates ALPHA-STAR Phase 1B/2 Clinical Trial Of STAR-0215 In People With HAE

Astria Therapeutics

08/02/2023 13:13

Feb 8 (Reuters) - Astria Therapeutics Inc  ATXS.O :
    * ASTRIA THERAPEUTICS INITIATES ALPHA-STAR PHASE 1B/2
CLINICAL
TRIAL OF STAR-0215 IN PEOPLE WITH HAE
    * ASTRIA THERAPEUTICS INC - INITIAL PROOF-OF-CONCEPT RESULTS
ANTICIPATED IN MID-2024
    * ASTRIA THERAPEUTICS INC- INITIAL PROOF-OF-CONCEPT RESULTS
ANTICIPATED IN MID-2024
    * ASTRIA THERAPEUTICS INC- IS PLANNING TO EVALUATE POTENTIAL
FOR
SIX-MONTH ADMINISTRATION OF STAR-0215 IN ADDITIONAL COHORTS IN
PHASE 1A TRIAL

Source text for Eikon:  ID:nBwbBJ9Qda 
Further company coverage:  ATXS.O 
 ((Reuters.Briefs@thomsonreuters.com;))